Identification of metabolites of meisoindigo in rat, pig and human liver microsomes by UFLC-MS/MS

Biochemical Pharmacology

Volumn 77, Issue 8, 2009, Pages 1418-1428

  Huang, Meng ^a   Ho, Paul C ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

In vitro metabolism; Interspecies differences; Liver microsomes; Meisoindigo; UFLC MS MS

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG METABOLITE; MEISOINDIGO; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DETERMINATION; DRUG HALF LIFE; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG STABILITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; SWINE; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; INDOLES; MALE; MICROSOMES, LIVER; MOLECULAR STRUCTURE; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; SWINE; TANDEM MASS SPECTROMETRY;

EID: 62549140533     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.01.012     Document Type: Article

References (18)

1. Cooperative Group of Clinical Therapy of Meisoindigo. Clinical studies of meisoindigo in the treatment of 134 patients with CML. Chin J Hematol 9 (1988) 135-137
2. Xiao Z.J., Hao Y.S., Liu B.C., and Qian L.S. Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China. Leuk Lymphoma 43 (2002) 1763-1768
3. Xiao Z.J., Qian L.S., Liu B.C., and Hao Y.S. Meisoindigo for the treatment of chronic myelogenous leukemia. Br J Haematol 111 (2000) 711-712
4. Peng Y., and Wang M.Z. Screening for in vitro metabolites of meisoindigo using RP-HPLC-DAD with gradient elution. Acta Pharmaceut Sin 25 (1990) 208-214
5. Huang M., Goh L.T., and Ho P.C. Identification of stereoisomeric metabolites of meisoindigo in rat liver microsomes by achiral and chiral LC-MS/MS. Drug Metab Dispos 36 (2008) 2171-2184
6. Shou W.Z., Magis L., Li A.C., Naidong W., and Bryant M.S. A novel approach to perform metabolite screening during the quantitative LC-MS/MS analyses of in vitro metabolic stability samples using a hybrid triple-quadrupole linear ion trap mass spectrometer. J Mass Spectrom 40 (2005) 1347-1356
7. Chen Y., Monshouwer M., and Fitch L.W. Analytical tools and approaches for metabolite identification in early drug discovery. Pharm Res 24 (2007) 248-257
8. Gibson G.G., and Skett P. Techniques and experiments illustrating drug metabolism. In: Gibson G.G., and Skett P. (Eds). Introduction to drug metabolism (1994), Blackie Academic and Professional, London 240-242
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
10. Obach R.S. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27 (1999) 1350-1359
11. Obach R.S., Baxter J.G., Liston T.E., Silber B.M., Jones B.C., MacIntyre F., et al. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J Pharmacol Exp Ther 283 (1997) 46-58
12. Davies B., and Morris T. Physiological parameters in laboratory animals and humans. Pharm Res 10 (1993) 1093-1095
13. Houston J.B. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 47 (1994) 1469-1479
14. Iwatsubo T., Hirota N., Ooie T., Suzuki H., Shimada N., Chiba K., et al. Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol Ther 73 (1997) 147-171
15. Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6 (1996) 1-42
16. Jurima-Romet M., Casley W.L., Leblanc C.A., and Nowakowska M. Evidence for the catalysis of dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver. Toxicol in Vitro 14 (2000) 253-263
17. Anzenbacher P., Anzerbacherova E., Zuber R., Soucek P., and Guengerich F.P. Pig and minipig cytochromes P450. Drug Metab Dispos 30 (2002) 100-102
18. Myers M.J., Farrell D.E., Howard K.D., and Kawalek J.C. Identification of multiple constitutive and inducible hepatic cytochrome P450 enzymes in market weight swine. Drug Metab Dispos 29 (2001) 908-915